Reuters |
Abbott, AbbVie to pay $25 million to settle TriCor marketing case
Reuters (Reuters) - Abbott Laboratories and AbbVie Inc will pay a total of $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for their prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes. |
October 26, 2018 at 04:08PM | marketing - Google News
Abbott, AbbVie to pay $25 million to settle TriCor marketing case - Reuters
marketing - Google News
Nenhum comentário:
Postar um comentário